Precision BioLogic develops, manufactures and markets innovative products for the clinical laboratory assessment of blood coagulation disorders. Precision's principal focus is in the field of hemostasis, for which the company has developed CRYOcheck, a line of specialized high-quality frozen plasmas, reagents and integrated test kits used in the assessment of hemostasis. Precision currently serves over 1,000 clinical laboratories throughout North America with direct overnight delivery and works with distribution partners to sell to customers overseas.